Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03039192
Brief Title: 54135419SUI3001: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide (Aspire I)

First Submitted : January 31, 2017
First Submitted that Met QC Criteria : January 31, 2017
First Posted : February 1, 2017 (Estimate)

Results First Submitted : September 1, 2020
Results First Submitted that Met QC Criteria : October 8, 2020
Results First Posted : October 29, 2020

Certification/Extension First Submitted : December 16, 2019
Certification/Extension First Submitted that Met QC Criteria : October 8, 2020
Certification/Extension First Posted : October 29, 2020

Last Update Submitted that Met QC Criteria : October 8, 2020
Last Update Posted : October 29, 2020